• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改善初级保健中的皮肤和软组织感染管理:来自科罗拉多州门诊实践和合作伙伴州网络(SNOCAP-USA)和治疗学分布式门诊研究网络(DARTNet)的报告。

Improving the management of skin and soft tissue infections in primary care: a report from State Networks of Colorado Ambulatory Practices and Partners (SNOCAP-USA) and the Distributed Ambulatory Research in Therapeutics Network (DARTNet).

机构信息

Department of Family Medicine, University of Colorado Denver, Aurora, Colorado, USA.

出版信息

J Am Board Fam Med. 2011 Sep-Oct;24(5):534-42. doi: 10.3122/jabfm.2011.05.110018.

DOI:10.3122/jabfm.2011.05.110018
PMID:21900436
Abstract

BACKGROUND

Purulent skin and soft tissue infections (SSTIs) requiring medical attention are often managed in primary care. The prevalence of SSTIs caused by community-acquired Methicillin-resistant Staphylococcus aureus (CA-MRSA) has been increasing rapidly, including in otherwise healthy individuals. The Centers for Disease Control and Prevention (CDC) issued guidelines to improve the management of SSTIs in primary care.

PURPOSE

In primary care settings, to assess the prevalence of CA-MRSA using an electronic chart audit and then evaluate SSTI management strategies consistent with CDC guidelines.

METHODS

A practical intervention that compared a historical cohort to an intervention cohort of patients seen for SSTI in 16 primary care practices in two health care systems. The intervention included a ready-made kit for I & D procedures, MRSA information for clinicians, a patient information handout, provider education, and patient follow-up.

RESULTS

A total of 3112 SSTI cases (cellulitis or purulent) were observed during the preintervention period and 1406 cases during the intervention. For purulent infections in the intervention period (n = 148), univariate and multivariate analyses showed no significant improvement in the rate of I & D procedures or cultures obtained but showed increased use of antibiotics overall and agents that typically cover MRSA strains (OR, 2.183; 95% CI, 1.443 to 3.303 and 2.624; 95% CI, 1.500 to 4.604, respectively). For infections that were cellulitis with or without purulence (n = 1258), overall rates in the use of antibiotics and those that cover MRSA increased significantly, but secular trends could not be ruled out as an explanation for this increase.

CONCLUSION

In SSTIs, this intervention resulted in increased use of antibiotics, including antibiotics that typically cover MRSA strains, but did not demonstrate increased rates of recommended drainage procedures. It is replicable and portable, and may improve antibiotic selection in other settings.

摘要

背景

需要医疗关注的脓性皮肤和软组织感染(SSTIs)通常在初级保健中进行管理。社区获得性耐甲氧西林金黄色葡萄球菌(CA-MRSA)引起的 SSTIs 的患病率一直在迅速增加,包括在原本健康的个体中。疾病控制与预防中心(CDC)发布了指南,以改善初级保健中 SSTIs 的管理。

目的

在初级保健环境中,使用电子图表审计评估 CA-MRSA 的患病率,然后评估符合 CDC 指南的 SSTI 管理策略。

方法

这是一项实用的干预措施,比较了两个医疗保健系统的 16 个初级保健实践中 SSTI 就诊的历史队列和干预队列。该干预措施包括用于切开和引流(I&D)程序的现成套件、临床医生的 MRSA 信息、患者信息传单、提供者教育和患者随访。

结果

在干预前期间观察到 3112 例 SSTI 病例(蜂窝织炎或脓性),在干预期间观察到 1406 例。在干预期间的脓性感染(n=148)中,单变量和多变量分析显示 I&D 程序或获得的培养物的比率没有显著改善,但总体上抗生素的使用增加了,并且通常覆盖 MRSA 菌株的抗生素也增加了(比值比,2.183;95%置信区间,1.443 至 3.303 和 2.624;95%置信区间,1.500 至 4.604)。对于有或没有脓性的蜂窝织炎感染(n=1258),抗生素和覆盖 MRSA 的抗生素的总体使用率显著增加,但不能排除这种增加是由于时间趋势造成的。

结论

在 SSTIs 中,这种干预措施导致抗生素的使用增加,包括通常覆盖 MRSA 菌株的抗生素,但没有显示出推荐引流程序的比率增加。它是可复制和可移植的,并可能改善其他环境中的抗生素选择。

相似文献

1
Improving the management of skin and soft tissue infections in primary care: a report from State Networks of Colorado Ambulatory Practices and Partners (SNOCAP-USA) and the Distributed Ambulatory Research in Therapeutics Network (DARTNet).改善初级保健中的皮肤和软组织感染管理:来自科罗拉多州门诊实践和合作伙伴州网络(SNOCAP-USA)和治疗学分布式门诊研究网络(DARTNet)的报告。
J Am Board Fam Med. 2011 Sep-Oct;24(5):534-42. doi: 10.3122/jabfm.2011.05.110018.
2
Management of skin and soft tissue infections in community practice before and after implementing a "best practice" approach: an Iowa Research Network (IRENE) intervention study.社区实践中实施“最佳实践”方法前后皮肤和软组织感染的管理:爱荷华州研究网络(IRENE)干预研究。
J Am Board Fam Med. 2011 Sep-Oct;24(5):524-33. doi: 10.3122/jabfm.2011.05.110017.
3
Emergency management of pediatric skin and soft tissue infections in the community-associated methicillin-resistant Staphylococcus aureus era.社区相关性耐甲氧西林金黄色葡萄球菌时代儿童皮肤和软组织感染的急症管理。
Acad Emerg Med. 2010 Feb;17(2):187-93. doi: 10.1111/j.1553-2712.2009.00652.x.
4
Practice patterns and management strategies for purulent skin and soft-tissue infections in an urban academic ED.城市学术急诊部脓性皮肤和软组织感染的治疗模式和管理策略。
Am J Emerg Med. 2012 Feb;30(2):302-10. doi: 10.1016/j.ajem.2010.11.033. Epub 2011 Jan 28.
5
Diagnostic and therapeutic evaluation of community-acquired methicillin-resistant Staphylococcus Aureus (MRSA) skin and soft tissue infections in the emergency department.急诊科社区获得性耐甲氧西林金黄色葡萄球菌(MRSA)皮肤及软组织感染的诊断与治疗评估
J Emerg Med. 2012 Apr;42(4):392-9. doi: 10.1016/j.jemermed.2011.03.009. Epub 2011 Apr 27.
6
National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections.门诊就诊及皮肤和软组织感染抗生素处方的全国趋势。
Arch Intern Med. 2008 Jul 28;168(14):1585-91. doi: 10.1001/archinte.168.14.1585.
7
Primary care clinicians' perspectives on management of skin and soft tissue infections: an Iowa Research Network study.初级保健临床医生对皮肤和软组织感染管理的看法:爱荷华州研究网络研究。
J Rural Health. 2011 Summer;27(3):319-28. doi: 10.1111/j.1748-0361.2010.00347.x. Epub 2010 Nov 15.
8
The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.基层医疗开方者在社区获得性耐甲氧西林金黄色葡萄球菌皮肤及软组织感染的诊断与管理中的作用
Am J Ther. 2009 Jul-Aug;16(4):333-8. doi: 10.1097/MJT.0b013e31817fdea8.
9
The role of antimicrobial therapy for treatment of uncomplicated skin and soft tissue infections from community-acquired methicillin-resistant Staphylococcus aureus in children.儿童社区获得性耐甲氧西林金黄色葡萄球菌所致单纯性皮肤软组织感染的抗菌治疗作用。
J Microbiol Immunol Infect. 2009 Aug;42(4):324-8.
10
Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome.社区获得性耐甲氧西林金黄色葡萄球菌皮肤和软组织感染:抗菌治疗对结局的影响。
Clin Infect Dis. 2007 Mar 15;44(6):777-84. doi: 10.1086/511872. Epub 2007 Feb 1.

引用本文的文献

1
Examining Workflow in a Pediatric Emergency Department to Develop a Clinical Decision Support for an Antimicrobial Stewardship Program.检查儿科急诊室的工作流程,为抗菌药物管理计划开发临床决策支持。
Appl Clin Inform. 2018 Apr;9(2):248-260. doi: 10.1055/s-0038-1641594. Epub 2018 Apr 11.
2
Clinical Study of an Online Tool for Standardizing Hospital Care.用于规范医院护理的在线工具的临床研究
J Healthc Qual. 2016 Nov/Dec;38(6):359-369. doi: 10.1097/JHQ.0000000000000070.
3
A Prescription for Resistance: Management of Staphylococcal Skin Abscesses by General Practitioners in Australia.
抗药处方:澳大利亚全科医生对葡萄球菌皮肤脓肿的管理
Front Microbiol. 2016 Jun 6;7:802. doi: 10.3389/fmicb.2016.00802. eCollection 2016.
4
The DARTNet Institute: Seeking a Sustainable Support Mechanism for Electronic Data Enabled Research Networks.DARTNet 研究所:为电子数据支持的研究网络寻求可持续的支持机制。
EGEMS (Wash DC). 2014 Sep 2;2(2):1063. doi: 10.13063/2327-9214.1063. eCollection 2014.
5
Community-associated methicillin-resistant Staphylococcus aureus in a pediatric emergency department in Newfoundland and Labrador.加拿大纽芬兰与拉布拉多省儿科急诊室的社区相关性耐甲氧西林金黄色葡萄球菌
Can J Infect Dis Med Microbiol. 2014 Spring;25(1):13-6. doi: 10.1155/2014/267901.
6
A data-driven mathematical model of CA-MRSA transmission among age groups: evaluating the effect of control interventions.基于数据驱动的 CA-MRSA 年龄组间传播数学模型:评估控制干预效果。
PLoS Comput Biol. 2013;9(11):e1003328. doi: 10.1371/journal.pcbi.1003328. Epub 2013 Nov 21.
7
Clonal distribution and possible microevolution of methicillin-resistant Staphylococcus aureus strains in a teaching hospital in Malaysia.马来西亚一家教学医院中耐甲氧西林金黄色葡萄球菌菌株的克隆分布及可能的微进化
Asian Pac J Trop Biomed. 2013 Mar;3(3):224-8. doi: 10.1016/S2221-1691(13)60055-6.